Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $19.41 million. The enterprise value is $15.10 million.

Market Cap	19.41M
Enterprise Value	15.10M

Important Dates

The last earnings date was Monday, November 4, 2024, after market close.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

UBX has 16.85 million shares outstanding. The number of shares has increased by 15.08% in one year.

Current Share Class	16.85M
Shares Outstanding	16.85M
Shares Change (YoY)	+15.08%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	9.14%
Float	14.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.39
P/TBV Ratio	1.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 1.73.

Current Ratio	3.45
Quick Ratio	3.31
Debt / Equity	1.73
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28,257.00

Financial Efficiency

Return on equity (ROE) is -86.95% and return on invested capital (ROIC) is -34.44%.

Return on Equity (ROE)	-86.95%
Return on Assets (ROA)	-30.34%
Return on Capital (ROIC)	-34.44%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.07% in the last 52 weeks. The beta is 0.83, so UBX's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-45.07%
50-Day Moving Average	1.37
200-Day Moving Average	1.50
Relative Strength Index (RSI)	36.20
Average Volume (20 Days)	76,122

Short Selling Information

The latest short interest is 303,044, so 1.80% of the outstanding shares have been sold short.

Short Interest	303,044
Short Previous Month	305,698
Short % of Shares Out	1.80%
Short % of Float	2.07%
Short Ratio (days to cover)	7.70

Income Statement

Revenue	n/a
Gross Profit	-18.39M
Operating Income	-28.26M
Pretax Income	-27.86M
Net Income	-21.89M
EBITDA	-27.36M
EBIT	-28.26M
Earnings Per Share (EPS)	-$1.32

Full Income Statement

Balance Sheet

The company has $29.04 million in cash and $24.43 million in debt, giving a net cash position of $4.61 million or $0.27 per share.

Cash & Cash Equivalents	29.04M
Total Debt	24.43M
Net Cash	4.61M
Net Cash Per Share	$0.27
Equity (Book Value)	14.14M
Book Value Per Share	0.84
Working Capital	21.48M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.54M
Capital Expenditures	n/a
Free Cash Flow	-22.54M
FCF Per Share	-$1.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.08%
Shareholder Yield	-15.08%
Earnings Yield	-111.05%
FCF Yield	-114.32%

Analyst Forecast

The average price target for UBX is $8.00, which is 594.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	594.44%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a